AGAPE ATP CORPORATION Proceeds from Common Stock Issued
AGAPE ATP CORPORATION (ATPC) reported Proceeds from Common Stock Issued of $23.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-14
- AGAPE ATP CORPORATION proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00.
- AGAPE ATP CORPORATION proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00.
- AGAPE ATP CORPORATION proceeds from issuance of common stock for the quarter ending 2025-06-30 was $0.00.
- AGAPE ATP CORPORATION proceeds from issuance of common stock for the quarter ending 2025-03-31 was $23.00M.
- AGAPE ATP CORPORATION proceeds from issuance of common stock for fiscal 2025 was $23.00M.
- AGAPE ATP CORPORATION proceeds from issuance of common stock for fiscal 2023 was $5.50M.
- AGAPE ATP CORPORATION proceeds from issuance of common stock for fiscal 2018 was $2.93M, a 23.54% increase from fiscal 2017.
- AGAPE ATP CORPORATION proceeds from issuance of common stock for fiscal 2017 was $2.37M.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $0.00 derived: sum of 2 quarters · filed 2026-04-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $23.00M 10-K · filed 2026-04-13 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $23.00M 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $23.00M 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $23.00M 10-Q · filed 2026-05-15 | ||||
| 2025-03-20 | $23.00M 10-Q · filed 2026-08-14 | ||||
| 2023-12-31 | $5.50M 10-K · filed 2025-03-31 | ||||
| 2018-06-30 | -$293.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.49M derived: sum of 2 quarters · filed 2020-03-27 | $2.93M 10-K · filed 2020-03-27 | ||
| 2018-03-31 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-13 | $2.93M 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $434.50K 10-Q · filed 2019-02-15 | ||||
| 2017-06-30 | $2.37M 10-K · filed 2018-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |